Medtronic PLC Company Insiders

MDT Stock  USD 88.08  0.92  1.06%   
Medtronic PLC employs about 95 K people. The company is managed by 45 executives with a total tenure of roughly 242 years, averaging almost 5.0 years of service per executive, having 2111.11 employees per reported executive. Breaking down Medtronic PLC's management performance can provide insight into the firm performance.
Omar Ishrak  Chairman
Chairman of the Board, Chief Executive Officer
Bradley Lerman  President
Senior Vice President General Counsel, Corporate secretary
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Medtronic PLC's latest congressional trading

Congressional trading in companies like Medtronic PLC, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medtronic PLC by those in governmental positions are based on the same information available to the general public.
2024-12-06Representative Ro KhannaAcquired Under $15KVerify
2024-09-12Senator Tommy TubervilleAcquired $15K to $50KVerify
2024-09-06Representative John JamesAcquired Under $15KVerify
2024-09-02Representative John JamesAcquired Under $15KVerify
2024-08-21Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-16Representative Kathy ManningAcquired Under $15KVerify
2024-08-06Representative Earl BlumenauerAcquired Under $15KVerify
2024-03-15Senator Shelley Moore CapitoAcquired Under $15KVerify
2024-03-14Senator Shelley Moore CapitoAcquired Under $15KVerify
2023-12-14Representative Debbie DingellAcquired $15K to $50KVerify
2023-10-20Senator Pete RickettsAcquired $50K to $100KVerify
2023-04-19Senator Tina SmithAcquired $100K to $250KVerify
2023-04-18Senator Tina SmithAcquired $100K to $250KVerify
2022-08-07Representative Alan S LowenthalAcquired Under $15KVerify
2022-08-04Representative Alan S LowenthalAcquired Under $15KVerify
2022-06-12Senator Roy BluntAcquired $15K to $50KVerify
2020-11-04Representative Alan S LowenthalAcquired Under $15KVerify
2016-10-04Senator Thomas R CarperAcquired Under $15KVerify
2016-10-03Senator Thomas R CarperAcquired Under $15KVerify
2015-02-25Senator Gary PetersAcquired $15K to $50KVerify
2015-02-24Senator Gary PetersAcquired $15K to $50KVerify

Medtronic PLC Management Team Effectiveness

The company has Return on Asset of 0.0442 % which means that on every $100 spent on assets, it made $0.0442 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0795 %, implying that it generated $0.0795 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities.

Medtronic PLC Workforce Comparison

Medtronic PLC is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 383,390. Medtronic PLC totals roughly 95,000 in number of employees claiming about 25% of equities under Health Care industry.
The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Medtronic PLC Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medtronic PLC insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Medtronic PLC Notable Stakeholders

A Medtronic PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medtronic PLC often face trade-offs trying to please all of them. Medtronic PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medtronic PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Omar IshrakChairman of the Board, Chief Executive OfficerProfile
Bradley LermanSenior Vice President General Counsel, Corporate secretaryProfile
Ryan WeispfenningVice President - Investor RelationsProfile
Hooman HakamiExecutive Vice President and Group President of the Medtronic Diabetes GroupProfile
Richard KuntzSenior Vice President and Chief Scientific, Clinical and Regulatory OfficerProfile
Robert WhiteExecutive Vice President and President of Medtronic’s Minimally Invasive Therapies GroupProfile
Frank ChanPresident MonitoringProfile
Sean SalmonExecutive Vice President and President, Diabetes Operating Unit, President, Cardiovascular PortfolioProfile
Carol SurfaceChief Human Resource Officer, Senior Vice PresidentProfile
Karen ParkhillChief Financial Officer, Executive Vice PresidentProfile
Geoffrey MarthaExecutive Vice President and President - Restorative Therapies GroupProfile
Robert HoedtExecutive Vice President and President - EMEA RegionProfile
Michael CoyleExecutive Vice President, Group President - Cardiac and Vascular GroupProfile
Gary CoronaSenior CFOProfile
Scott DonnellyLead Independent DirectorProfile
Richard AndersonLead Independent DirectorProfile
Elizabeth NabelIndependent DirectorProfile
James LenehanIndependent DirectorProfile
Craig ArnoldIndependent DirectorProfile
Kendall PowellLead Independent DirectorProfile
Denise OLearyIndependent DirectorProfile
Michael LeavittIndependent DirectorProfile
Randall HoganIndependent DirectorProfile
Andrea GoldsmithIndependent DirectorProfile
Joon HurhVP PacificProfile
Ivan FongGeneral VPProfile
Brett WallExecutive Vice President and President Restorative Therapies GroupProfile
Jennifer KirkChief Accounting Officer, Global ControllerProfile
Scott CundySenior OfficerProfile
Kenneth WashingtonSenior OfficerProfile
Mark PloofSenior ServicesProfile
Sean LennonChief OfficerProfile
Mei JiangSenior InnovationProfile
John LiddicoatExecutive Vice President and President Americas RegionProfile
Kevin LoftonIndependent DirectorProfile
Olaf HedrichChief OfficerProfile
Sally SabaChief Inclusion and Diversity OfficerProfile
Brad LermanSenior Vice President General Counsel, Corporate secretaryProfile
Matt WalterChief OfficerProfile
Torod NeptuneSenior OfficerProfile
Que DallaraExecutive UnitProfile
Gregory SmithExecutive ChainProfile
Robert HopkinsSenior StrategyProfile
MSc MDMedical ScientificProfile
MPH MDChief BusinessProfile

About Medtronic PLC Management Performance

The success or failure of an entity such as Medtronic PLC often depends on how effective the management is. Medtronic PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medtronic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medtronic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 95000 people.
Please note, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Check Medtronic PLC's Beneish M Score to see the likelihood of Medtronic PLC's management manipulating its earnings.

Medtronic PLC Workforce Analysis

Traditionally, organizations such as Medtronic PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medtronic PLC within its industry.

Medtronic PLC Manpower Efficiency

Return on Medtronic PLC Manpower

Revenue Per Employee340.7K
Revenue Per Executive719.2M
Net Income Per Employee38.7K
Net Income Per Executive81.7M
Working Capital Per Employee117.3K
Working Capital Per Executive247.7M

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.